மூன்றில் ஒரு பங்கு இறப்பை இந்த மருந்து தடுக்கும் ?! #Corona #COVID19
- 4 years ago
#Corona #Covid19 #Dexamethasone
Until this week there was no medicine proven to save lives. Now we have dexamethasone, which cuts the risk of death for patients on a ventilator by a third, and for those on oxygen by a fifth.It came about due to the persistence and single-mindedness of a small team at Oxford University, the co-operation of hospitals across the UK and the agreement of thousands of patients and their families.The Recovery trial was set up in nine days, and has recruited 11,500 Covid patients in 175 hospitals across the UK.
The UK Government has authorised the use of anti-inflammatory drug dexamethasone for the treatment of Covid-19 on the National Health Service (NHS), immediately after the report of positive data from the RECOVERY trial.
Preliminary data showed that the low-cost, commonly available drug reduced death by up to one third in hospitalised patients with severe respiratory complications caused by Covid-19.
Vikatan App-ல் தினமும் வேட்டை Daily 5 PM to 7 PM விகடன் DAILY QUIZ Challenge-ல சிம்பிளா பதில் சொல்லுங்க... செமயா ரூ.500 மதிப்புள்ள பரிசு வெல்லுங்க!
https://vikatanapp.page.link/DailyQuiz
CREDITS
Voice- Soundarya| Script - Jeni Freeda | Edit - Senthil Kumar
Vikatan App - http://bit.ly/2Sks6FG
Subscribe Vikatan Tv : https://goo.gl/wVkvNp
Until this week there was no medicine proven to save lives. Now we have dexamethasone, which cuts the risk of death for patients on a ventilator by a third, and for those on oxygen by a fifth.It came about due to the persistence and single-mindedness of a small team at Oxford University, the co-operation of hospitals across the UK and the agreement of thousands of patients and their families.The Recovery trial was set up in nine days, and has recruited 11,500 Covid patients in 175 hospitals across the UK.
The UK Government has authorised the use of anti-inflammatory drug dexamethasone for the treatment of Covid-19 on the National Health Service (NHS), immediately after the report of positive data from the RECOVERY trial.
Preliminary data showed that the low-cost, commonly available drug reduced death by up to one third in hospitalised patients with severe respiratory complications caused by Covid-19.
Vikatan App-ல் தினமும் வேட்டை Daily 5 PM to 7 PM விகடன் DAILY QUIZ Challenge-ல சிம்பிளா பதில் சொல்லுங்க... செமயா ரூ.500 மதிப்புள்ள பரிசு வெல்லுங்க!
https://vikatanapp.page.link/DailyQuiz
CREDITS
Voice- Soundarya| Script - Jeni Freeda | Edit - Senthil Kumar
Vikatan App - http://bit.ly/2Sks6FG
Subscribe Vikatan Tv : https://goo.gl/wVkvNp